首页> 外文期刊>Veterinary Research Communications >Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study
【24h】

Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study

机译:癌症抗原15/3:在兽医临床肿瘤学中可能的诊断用途。初步研究

获取原文
获取原文并翻译 | 示例
       

摘要

The cancer antigen 15/3 is a mucin that is associated with the cell membrane, encoded by the MUC1 gene, and recognized by the monoclonal-clone DF3 antibody. The latter antigen was discovered to be specific for both the identification of human mammary neoplasia and during patient follow-up evaluations. The aim of this study is to report and compare the results of the application of direct chemiluminescence in canine blood sera and the kit utilized in human medicine for the determination of Ca 15/3 to verify the diagnostic efficiency of the kit in cases presenting mammary tumors. Specifically, CA 15/3 has proven to be measurable in all samples assayed to distinguish clinically healthy subjects from those with mammary neoplasia.
机译:癌症抗原15/3是一种粘蛋白,与细胞膜相关,由MUC1基因编码,并被单克隆DF3抗体识别。发现后一种抗原对人类乳腺肿瘤的鉴定和患者随访评估均具有特异性。这项研究的目的是报告和比较直接化学发光法在犬血血清中的应用结果,以及用于人类药物测定Ca 15/3的试剂盒,以验证该试剂盒在乳腺肿瘤病例中的诊断效率。具体而言,事实证明,CA 15/3在所有用于区分临床健康受试者和乳腺肿瘤的受试者中均可以测量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号